Free shipping on all orders over $ 500

SP-100030 

Cat. No. M28589

All AbMole products are for research use only, cannot be used for human consumption.

SP-100030  Structure

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.

Quality Control & Documentation
Biological Activity

SP-100030 is a potent NF-κB and activator protein-1 (AP-1) double inhibitor (IC50s=50 and 50 nM, respectively). SP-100030 inhibits IL-2, IL-8, and TNF-alpha production in Jurkat and other T cell lines. SP-100030 decreases murine collagen-induced arthritis (CIA).

Chemical Information
Molecular Weight 437.65
Formula C14H5ClF9N3O
CAS Number 154563-54-9
Form Solid
Solubility (25°C) DMSO 50 mg/mL (ultrasonic)
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Na Ye, et al. J Med Chem. Small molecule inhibitors targeting activator protein 1 (AP-1)

[2] Rodrigo Moore-Carrasco, et al. Anticancer Res. Both AP-1 and NF-kappaB seem to be involved in tumour growth in an experimental rat hepatoma

[3] Hajime Fujimoto, et al. Am J Respir Crit Care Med. Inhibition of nuclear factor-kappaB in T cells suppresses lung fibrosis

[4] Rodrigo Moore-Carrasco, et al. Int J Oncol. The AP-1/NF-kappaB double inhibitor SP100030 can revert muscle wasting during experimental cancer cachexia

[5] Deborah Phippard, et al. Methods Mol Biol. Screening for inhibitors of transcription factors using luciferase reporter gene expression in transfected cells

Related NF-κB Products
DCZ5418 

DCZ5418 is an inhibitor of TRIP13.
Ro 106-9920 

Ro 106-9920 is a potent inhibitor of NF-kappaB.
MRS2693 trisodium 

MRS2693 trisodium is a selective P2Y6 agonist with an EC50 value of 0.015 μM.
PTD-p65-P1 Peptide TFA

PTD-p65-P1 Peptide TFA is a potent, selective nuclear transcription factor NF-κB inhibitor and derives from the p65 subunit of NF-κB amino acid residues 271-282, which selectively inhibits NF-κB activation induced by various inflammatory stimulation, down-regulate NF-κB-mediated gene expression and up-regulate apoptosis.
Narlumosbart

Narlumosbart is a human IgG4ҡ monoclonal antibody (mAb) that targets Receptor Activating Factor for Nuclear Factor κB Ligand (RANKL) and can be used in studies related to Giant Cell Tumor of Bone (GCTB).
  Catalog
Abmole Inhibitor Catalog




Keywords: SP-100030  supplier, NF-κB, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.


 
Get to Know Us
Customer Support
Resources
Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.